Pacing and Clinical Electrophysiology 2007-08-01

QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.

Jarosław Kaźmierczak, Małgorzata Peregud-Pogorzelska, Ryszard Rzeuski

Index: Pacing Clin. Electrophysiol. 30(8) , 1043-6, (2007)

Full Text: HTML

Abstract

The presented case report describes a male patient with an implanted cardioverter-defibrillator (ICD) in whom a coadministration of ciprofloxacin and azimilide caused QT interval prolongation and multiple episodes of torsades de pointes (TdP) followed by ICD shocks (arrhythmic storm). The case highlights a not described drug interaction between azimilide and ciprofloxacin, which is believed to be the safest member of fluoroquinolones class.

Related Compounds

  • Azimilide (Dihydr...

Related Articles:

Azimilide dihydrochloride: a new class III anti-arrhythmic agent.

2000-11-01

[Expert Opin. Investig. Drugs 9(11) , 2705-15, (2000)]

Electrophysiological and antiarrhythmic effects of the novel antiarrhythmic agent AZD7009: a comparison with azimilide and AVE0118 in the acutely dilated right atrium of the rabbit in vitro.

2006-07-01

[Europace 8(7) , 549-57, (2006)]

Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.

2008-02-01

[J. Cardiovasc. Electrophysiol. 19(2) , 172-7, (2008)]

Role of drug therapy for sustained ventricular tachyarrhythmias.

2008-08-01

[Cardiol. Clin. 26(3) , 405-18, vi, (2008)]

Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.

2007-11-01

[J. Pharmacol. Sci. 105(3) , 229-39, (2007)]

More Articles...